His scientific interests lie mostly in Positron emission tomography, Internal medicine, Pathology, Endocrinology and Nuclear medicine. His Positron emission tomography study is associated with Neuroscience. His Internal medicine research includes elements of Anesthesia and Cardiology.
As part of his studies on Pathology, Bengt Långström often connects relevant subjects like Central nervous system disease. His work carried out in the field of Nuclear medicine brings together such families of science as Breast cancer, Mammary gland, Urinary system, Carcinoma and Computed tomography. His study looks at the relationship between In vivo and topics such as Biochemistry, which overlap with DOTA.
His main research concerns Positron emission tomography, Internal medicine, Endocrinology, Organic chemistry and In vivo. His Positron emission tomography study integrates concerns from other disciplines, such as Positron, Nuclear magnetic resonance and Pathology. Bengt Långström studies Receptor, a branch of Internal medicine.
The study of Endocrinology is intertwined with the study of Serotonin in a number of ways. His In vivo study frequently draws parallels with other fields, such as Biochemistry. He combines subjects such as Radiochemistry and Stereochemistry with his study of Methyl iodide.
The scientist’s investigation covers issues in Internal medicine, Positron emission tomography, Endocrinology, Pathology and Nuclear medicine. His work in Internal medicine tackles topics such as Social anxiety which are related to areas like Clinical psychology. His Positron emission tomography research incorporates themes from Amyloid, Principal component analysis, Artificial intelligence, Pattern recognition and Alzheimer's disease.
His work carried out in the field of Alzheimer's disease brings together such families of science as Central nervous system disease and Neuroscience. He focuses mostly in the field of Endocrinology, narrowing it down to topics relating to Serotonin and, in certain cases, Pharmacology. His Pathology research is multidisciplinary, incorporating elements of Neurology and In vivo.
His primary areas of study are Positron emission tomography, Internal medicine, Endocrinology, Alzheimer's disease and Pathology. His Positron emission tomography research entails a greater understanding of Nuclear medicine. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Posterior cingulate.
The study incorporates disciplines such as Acetylcholinesterase and Social anxiety, Anxiety in addition to Endocrinology. His Alzheimer's disease research integrates issues from Neuroscience, Nicotine and Nicotinic agonist. In his work, Csf biomarkers and Human brain is strongly intertwined with In vivo, which is a subfield of Pathology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.
William E. Klunk;Henry Engler;Agneta Nordberg;Yanming Wang.
Annals of Neurology (2004)
Imaging dopamine receptors in the human brain by positron tomography
Henry N. Wagner;H. Donald Burns;Robert F. Dannals;Dean F. Wong.
Science (1983)
Imaging dopamine receptors in the human brain by positron tomography
H. N. Wagner;H. D. Burns;R. F. Dannals;D. F. Wong.
Science (1983)
Common Changes in Cerebral Blood Flow in Patients With Social Phobia Treated With Citalopram or Cognitive-Behavioral Therapy
Tomas Furmark;Maria Tillfors;Ina Marteinsdottir;Håkan Fischer.
Archives of General Psychiatry (2002)
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
Henry Engler;Anton Forsberg;Ove Almkvist;Gunnar Blomquist.
Brain (2006)
Cerebral blood flow in subjects with social phobia during stressful speaking tasks: a PET study.
Maria Tillfors;Tomas Furmark;Ina Marteinsdottir;Håkan Fischer.
American Journal of Psychiatry (2001)
Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET.
J. S. Fowler;R. R. MacGregor;A. P. Wolf;C. D. Arnett.
Science (1987)
The use of PET in Alzheimer disease
Agneta Nordberg;Juha O. Rinne;Ahmadul Kadir;Bengt Långström.
Nature Reviews Neurology (2010)
Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development
Mats Bergström;Anders Grahnén;Anders Grahnén;Bengt Långström.
European Journal of Clinical Pharmacology (2003)
Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(β-11C) DOPA and PET
Leif H Lindström;Ola Gefvert;Gisela Hagberg;Tommie Lundberg.
Biological Psychiatry (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Karolinska University Hospital
Osaka Metropolitan University
Karolinska Institute
Uppsala University
Stockholm County Council
Uppsala University
University of Oxford
Linköping University
Uppsala University Hospital
Uppsala University
Arizona State University
University of Liverpool
University of Turin
United States Air Force Research Laboratory
California University of Pennsylvania
University of Minnesota
City University of Hong Kong
Tufts University
University of Cincinnati Medical Center
Chosun University
Miguel Hernandez University
Virginia Commonwealth University
University of Tasmania
University of Washington
University of Genoa
University of Bologna